These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25822852)
1. Discovery of Small Molecules for Up-Regulating the Translation of Antiamyloidogenic Secretase, a Disintegrin and Metalloproteinase 10 (ADAM10), by Binding to the G-Quadruplex-Forming Sequence in the 5' Untranslated Region (UTR) of Its mRNA. Dai J; Liu ZQ; Wang XQ; Lin J; Yao PF; Huang SL; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS J Med Chem; 2015 May; 58(9):3875-91. PubMed ID: 25822852 [TBL] [Abstract][Full Text] [Related]
2. Translational repression of the disintegrin and metalloprotease ADAM10 by a stable G-quadruplex secondary structure in its 5'-untranslated region. Lammich S; Kamp F; Wagner J; Nuscher B; Zilow S; Ludwig AK; Willem M; Haass C J Biol Chem; 2011 Dec; 286(52):45063-72. PubMed ID: 22065584 [TBL] [Abstract][Full Text] [Related]
3. Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region. Lammich S; Buell D; Zilow S; Ludwig AK; Nuscher B; Lichtenthaler SF; Prinzen C; Fahrenholz F; Haass C J Biol Chem; 2010 May; 285(21):15753-60. PubMed ID: 20348102 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882 [TBL] [Abstract][Full Text] [Related]
5. An unusually stable G-quadruplex within the 5'-UTR of the MT3 matrix metalloproteinase mRNA represses translation in eukaryotic cells. Morris MJ; Basu S Biochemistry; 2009 Jun; 48(23):5313-9. PubMed ID: 19397366 [TBL] [Abstract][Full Text] [Related]
6. Regulation of α-secretase ADAM10 expression and activity. Endres K; Fahrenholz F Exp Brain Res; 2012 Apr; 217(3-4):343-52. PubMed ID: 21969210 [TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP. Corbett GT; Gonzalez FJ; Pahan K Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of the alpha-secretase ADAM10--risk or reason for hope? Endres K; Fahrenholz F FEBS J; 2010 Apr; 277(7):1585-96. PubMed ID: 20136654 [TBL] [Abstract][Full Text] [Related]
10. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17. Shukla M; Htoo HH; Wintachai P; Hernandez JF; Dubois C; Postina R; Xu H; Checler F; Smith DR; Govitrapong P; Vincent B J Pineal Res; 2015 Mar; 58(2):151-65. PubMed ID: 25491598 [TBL] [Abstract][Full Text] [Related]
11. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease. Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480 [TBL] [Abstract][Full Text] [Related]
12. Retinoids as a perspective in treatment of Alzheimer's disease. Fahrenholz F; Tippmann F; Endres K Neurodegener Dis; 2010; 7(1-3):190-2. PubMed ID: 20224284 [TBL] [Abstract][Full Text] [Related]
13. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10. Parkin E; Harris B J Neurochem; 2009 Mar; 108(6):1464-79. PubMed ID: 19183255 [TBL] [Abstract][Full Text] [Related]
14. Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease. Laws SM; Eckart K; Friedrich P; Kurz A; Förstl H; Riemenschneider M Neurobiol Aging; 2011 Mar; 32(3):541-3. PubMed ID: 19344981 [TBL] [Abstract][Full Text] [Related]
15. Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative alpha-secretases, ADAM10 and TACE, without altering their mRNA levels. Marshall AJ; Rattray M; Vaughan PF Brain Res; 2006 Jul; 1099(1):18-24. PubMed ID: 16762326 [TBL] [Abstract][Full Text] [Related]
16. Acitretin, an enhancer of alpha-secretase expression, crosses the blood-brain barrier and is not eliminated by P-glycoprotein. Holthoewer D; Endres K; Schuck F; Hiemke C; Schmitt U; Fahrenholz F Neurodegener Dis; 2012; 10(1-4):224-8. PubMed ID: 22301853 [TBL] [Abstract][Full Text] [Related]
17. Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Endres K; Mitteregger G; Kojro E; Kretzschmar H; Fahrenholz F Neurobiol Dis; 2009 Nov; 36(2):233-41. PubMed ID: 19632330 [TBL] [Abstract][Full Text] [Related]
18. The retinoic acid receptor agonist Am80 increases hippocampal ADAM10 in aged SAMP8 mice. Kitaoka K; Shimizu N; Ono K; Chikahisa S; Nakagomi M; Shudo K; Ishimura K; Séi H; Yoshizaki K Neuropharmacology; 2013 Sep; 72():58-65. PubMed ID: 23624141 [TBL] [Abstract][Full Text] [Related]
19. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells. Yuan S; Lei S; Wu S Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592 [TBL] [Abstract][Full Text] [Related]
20. Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme. Musumeci G; Magro G; Cardile V; Coco M; Marzagalli R; Castrogiovanni P; Imbesi R; Graziano AC; Barone F; Di Rosa M; Castorina S; Castorina A Cell Tissue Res; 2015 Oct; 362(1):45-60. PubMed ID: 25948484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]